The Current Status of Combined Radiotherapy and Chemotherapy for Locally Advanced or Resected Pancreas Cancer

Restricted access

Pancreas cancer is the fourth most common cause of cancer deaths. Even for the small percentage of patients who can undergo surgical resection of the primary tumor, the risk of recurrence remains unacceptably high. For patients with localized disease that is not amenable to surgical resection, pain related to the primary tumor can significantly impair quality of life. Attempts to improve the duration and quality of life for these patients have included both chemotherapy and radiotherapy. The addition of chemotherapy to radiation may enhance the local effects of radiation or provide treatment of disease outside the radiation field. The results of clinical trials evaluating the appropriate therapy for locally advanced or resected disease have been inconsistent. In some instances, the methods used in these studies became outdated before the results were available. Hopefully, advances in radiation techniques and systemic drug therapy will provide more durable and clinically relevant results. Meanwhile, treatment decisions should be tailored to the clinical situation, including consideration of treatment toxicity and therapy goals. Recognizing which patients are likely to benefit from combination therapy or systemic therapy alone is a subject of future and ongoing clinical trials.

Correspondence: Mary F. Mulcahy, MD, Department of Medicine, Division of Hematology/Oncology, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, 676 North Saint Clair, Suite 850, Chicago, IL 60611. E-mail: m-mulcahy@northwestern.edu
  • 1

    JemalAMurrayTWardE. Cancer statistics, 2005. CA Cancer J Clin2005:55:1030.

  • 2

    BurrisHA3rdMooreMJAndersonJ. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol1997;15:24032413.

    • Search Google Scholar
    • Export Citation
  • 3

    NeoptolemosJPStockenDDFriessH. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med2004;350: 12001210.

    • Search Google Scholar
    • Export Citation
  • 4

    NeuhausPOHPostSGellertK. A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer. J Clin Oncol2005;23(suppl): 1092S.

    • Search Google Scholar
    • Export Citation
  • 5

    TepperJNardiGSuttH. Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy. Cancer1976;37:15191524.

    • Search Google Scholar
    • Export Citation
  • 6

    GriffinJFSmalleySRJewellW. Patterns of failure after curative resection of pancreatic carcinoma. Cancer1990;66:5661.

  • 7

    WhittingtonRBryerMPHallerDG. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys1991;21:11371143.

    • Search Google Scholar
    • Export Citation
  • 8

    AbramsRA. Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985?Int J Radiat Oncol Biol Phys2003;56(suppl):39.

    • Search Google Scholar
    • Export Citation
  • 9

    KaoGDWhittingtonRCoiaL. Anatomy of the celiac axis and superior mesenteric artery and its significance in radiation therapy. Int J Radiat Oncol Biol Phys1993;25: 131134.

    • Search Google Scholar
    • Export Citation
  • 10

    KomakiRWadlerSPetersT. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801). Cancer1992;69:28072812.

    • Search Google Scholar
    • Export Citation
  • 11

    HallEJ. Radiobiology for the Radiologist5th ed. Philadelphia, PA: Lippincott Williams & Wilkins2000; pp 1731.

  • 12

    LawrenceTSTepperJEBlackstockAW. Fluoropyrimidine-radiation interactions in cells and tumors. Semin Radiat Oncol1997;7:260266.

  • 13

    SterenASevinBUPerrasJ. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol Oncol1993;48:252258.

  • 14

    ShewachDSLawrenceTS. Radiosensitization of human solid tumor cell lines with gemcitabine. Semin Oncol1996;23(Suppl 10):6571.

  • 15

    MoertelCGFrytakSHahnRG. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer1981;48:17051710.

    • Search Google Scholar
    • Export Citation
  • 16

    Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst1988;80:751755.

    • Search Google Scholar
    • Export Citation
  • 17

    Gastrointestinal Tumor Study Group. Radiation therapy combined with adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Cancer1985;56:25632568.

    • Search Google Scholar
    • Export Citation
  • 18

    SeydelHGStableinDMLeichmanLP. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience. Cancer1990;65:14781482.

    • Search Google Scholar
    • Export Citation
  • 19

    WhittingtonRNeubergDTesterWJ. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol1995;13:227232.

    • Search Google Scholar
    • Export Citation
  • 20

    OstiMFCostaAMBianciardiF. Concomitant radiotherapy with protracted 5-fluorouracil infusion in locally advanced carcinoma of the pancreas: a phase II study. Tumori2001;87:398401.

    • Search Google Scholar
    • Export Citation
  • 21

    BozGDe PaoliAInnocenteR. Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma. Int J Radiat Oncol Biol Phys2001;51:736-740.

    • Search Google Scholar
    • Export Citation
  • 22

    KalserMHEllenbergSS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg1985;120:899903.

    • Search Google Scholar
    • Export Citation
  • 23

    Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer1987;59:20062010.

    • Search Google Scholar
    • Export Citation
  • 24

    KlinkenbijlJHJeekelJSahmoudT. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg1999;230:776782; discussion 782–784.

    • Search Google Scholar
    • Export Citation
  • 25

    CraneCBen-JosefESmallW.Jr.Chemotherapy for pancreatic cancer. NEJM2004;350:27132715.

  • 26

    PicozziVJKozarekRATraversoLW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg2003;185:476480.

    • Search Google Scholar
    • Export Citation
  • 27

    BlackstockAWTepperJENiedwieckiD. Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. Int J Gastrointest Cancer2003;34:107116.

    • Search Google Scholar
    • Export Citation
  • 28

    TalamontiMSCatalanoPJVaughnDJ. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol2000;18:33843389.

    • Search Google Scholar
    • Export Citation
  • 29

    McGinnCJZalupskiMMShureiqiI. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol2001;19:42024208.

    • Search Google Scholar
    • Export Citation
  • 30

    TalamontiMSSmallWJr.MulcahyMF. A Multi-Institutional Phase II Trial of Preoperative Full Dose Gemcitabine and Concurrent Radiation for Patients with Potentially Resectable Pancreatic Carcinoma. Ann Surg OncolOctober2005in press.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 45 45 3
PDF Downloads 11 11 0
EPUB Downloads 0 0 0